Slfn14 Inhibitors
Slfn14 inhibitors such as Decitabine and JQ1 target the epigenetic regulation and chromatin remodeling processes, potentially leading to alterations in the expression levels of Slfn14. Compounds like Curcumin exert their effects by influencing the activity of transcription factors that can regulate the expression of Slfn14. Inhibitors of signaling molecules, including SP600125, SB203580, and LY294002, can modify the intracellular signaling networks that Slfn14 may be a part of, thereby influencing the protein's regulatory capacity. Z-VAD-FMK, by inhibiting caspases, affects apoptotic processes that could alter the cellular environment in which Slfn14 functions.
Furthermore, metabolic inhibitors like 2-Deoxy-D-glucose can impact the energy status of the cell, which may affect the activity of Slfn14 if it is sensitive to changes in cellular energy levels. Rapamycin and Bortezomib intervene in fundamental cellular processes such as protein synthesis, autophagy, and proteostasis, potentially leading to changes in the abundance and function of Slfn14. Thapsigargin and Chloroquine can induce stress responses and inhibit autophagic flux, respectively, which could also alter the functional context of Slfn14.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor that can alter gene expression and might affect Slfn14 transcription levels. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
A BET bromodomain inhibitor that can modulate chromatin structure and influence gene expression, possibly affecting Slfn14 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound with multiple cellular targets that can modulate transcription factor activity, possibly impacting Slfn14 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can affect the JNK signaling pathway, potentially altering the signaling context in which Slfn14 operates. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can affect stress response pathways, potentially influencing Slfn14 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can affect AKT signaling, possibly impacting pathways that regulate Slfn14 activity. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor that can prevent apoptosis, possibly affecting the cellular context for Slfn14 activity during stress responses. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor that can alter cellular metabolism, potentially influencing Slfn14 by altering cellular energy balance. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can affect protein synthesis and autophagy, potentially modulating Slfn14 levels and function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can prevent the degradation of proteins, possibly stabilizing Slfn14 and affecting its cellular concentration. | ||||||